Novartis Pharmaceuticals Canada Inc. is pleased to announce the successful conclusion of negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public reimbursement of Leqvio® ...

Filings both for the obicetrapib monotherapy and obicetrapib plus ezetimibe fixed-dose combination submitted to EMA by our partner, Menarini, for treatment of adults with primary hypercholesterolemia ...

Company N.V. announced that the European Medicines Agency, EMA, has validated the Marketing Authorization Application, ...

Shot can act as a molecular linker between microtubules and actin during dendrite pruning, suggesting an intriguing role in non-centrosomal microtubule organization. However, the experimental evidence ...

CBSE Class 10 Science Half Yearly Sample Paper 2025 with solution. Explore the article to download the cbse class 10 sample ...

Scientists have identified a breakdown in cholesterol transport to neurons in Alzheimer’s disease, a defect linked to the ...

This study is valuable for understanding how dysfunctional mitochondria contribute to vascular diseases by investigating the influence of Miro1 on smooth muscle cell proliferation and neointima ...

(MENAFN- GetNews) "PCSK9 Inhibitors Market"The PCSK9 Inhibitors market size reached ~USD 2 billion in 2023 in 7MM and is ...

On track to report topline data by mid-Q4 2025 from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN, a severe, rare form of dementia with no approved treatments Ongoing Phase 2 ...

Researchers used whole-genome sequencing from diverse populations to identify 156 variants, including 133 novel ones, linked ...